drugset / Trial / NCT00846716
Shiga Progression of Diabetes, Nephropathy and Retinopathy
Unknown
400 enrolled
Shiga University
Ako City Hospital · collabHoride Clinic · collabHyogo prefectural Amagasaki Hospital · collabKanazawa Medical University · collabKawabata Clinic · collabKohka Public Hospital · collabNTT West Osaka Hospital · collabNagahama City Hospital · collabNagahama Red Cross Hospital · collabOmihachiman COmmunity Medical Center · collabOsaka University · collabSawada Clinic · collabSecond Okamoto General Hospital · collabSeta Clinic · collabShiga Clinic · collabSocial Insurance Shiga Hospital · collabTomita Clinic · collabToyosato Hospital · collabYasu Hospital · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to investigate whether the oral anti-diabetic drug, Thiazolidine (TZD) is effective in suppression of onset or progressin of diabetic nephropathy in Japanese type 2 diabetic patients.
Timeline
- Start
- 2008-03
- Primary completion
- 2011-11
- Completion
- 2011-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pioglitazone | Small molecule | 15 mg | Oral |